EUVIMEDEUVIMED entdecken
Open Access

Abaloparatide Enhances Bone Regeneration in Extraction Socket Dental Implant Defects: An Experimental In Vivo Study

Jessica Latimer iD, Birtan Yilmaz, Balazs Feher, Takahiko Shiba, Tobias Fretwurst iD, Bruce Mitlak, Beate Lanske, Paul Kostenuik, William V Giannobile iD

Clinical Oral Implants Research · 2025-04 · 36 (4) · 471-480

DOI: 10.1111/clr.14397 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oral Implants Research, online erschienen am 09.01.2025. Verfasst von Jessica Latimer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Bone Regeneration, Tooth Socket, Parathyroid Hormone-Related Protein, Dental Implants. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIDCR NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Abaloparatide (ABL) is a synthetic parathyroid hormone‐related protein analog developed as an anabolic drug to treat osteoporosis. ABL increases bone mineral density (BMD) of the long bones and spine; however, the influence of ABL on alveolar bone regeneration remains unknown. This study assessed the effects of systemic ABL administration on tooth extraction socket healing and dental implant osseointegration in a preclinical rodent model.

Methods

Sprague‐Dawley rats received daily subcutaneous injection of ABL (25 μg/kg) or vehicle (VEH) at the time of maxillary first molar (M1) extraction surgery; animals underwent either: (1) unilateral M1 extraction followed by sacrifice at 10 or 42d or (2) bilateral M1 extraction followed by staged implant placement in osteotomies with standardized defects and sacrifice at 21 or 28d.

Results

Micro‐computed tomography (micro‐CT) analysis demonstrated that ABL increased bone volume fraction ( p = 0.004) and bone mineral density (BMD) ( p = 0.006) of regenerated extraction sockets at 42d. Micro‐CT of the femur validated systemic effects of ABL, showing greater trabecular BMD after 6 ( p < 0.01), 9 ( p < 0.001), and 14 ( p < 0.001) weeks of treatment. Histomorphometry confirmed a higher mineralized bone area with ABL treatment in extraction sockets at 42d ( p = 0.03) and in the regenerated peri‐implant bone at 21d post‐implant placement ( p = 0.01) compared to control.

Conclusion

Systemic ABL administration enhances osteogenesis in extraction sockets prior to implant placement and accelerates peri‐implant bone formation in the early phase of healing in the present rodent model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone RegenerationTooth SocketParathyroid Hormone-Related ProteinDental ImplantsBone Density Conservation AgentsAnimalsRats, Sprague-DawleyX-Ray MicrotomographyRatsTooth ExtractionBone DensityOsseointegrationMaleDental Implantation, Endosseous

Stichwörter der Autor:innen

anabolicsbone repair/regenerationoral implantosseointegrationosteoporosistooth extraction

Substanzen

abaloparatideParathyroid Hormone-Related ProteinDental ImplantsBone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts, USA.
  • Department of Oral Biology, University Clinic of Dentistry, Medical University of Vienna, Vienna, Austria.
  • Department of Oral Surgery, University Clinic of Dentistry, Medical University of Vienna, Vienna, Austria.
  • Department of Periodontology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Department of Oral and Craniomaxillofacial Surgery/Translational Implantology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
  • Radius Health Inc., Boston, Massachusetts, USA.

ORCID-Profile: Jessica Latimer, Tobias Fretwurst, William V Giannobile

Förderung

  • NIAMS NIH HHS
  • NIDCR NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Latimer, J., Yilmaz, B., Feher, B., Shiba, T., Fretwurst, T., Mitlak, B., Lanske, B., Kostenuik, P., & Giannobile, W. V. (2025). Abaloparatide Enhances Bone Regeneration in Extraction Socket Dental Implant Defects: An Experimental In Vivo Study. Clinical Oral Implants Research, 36(4), 471-480. https://doi.org/10.1111/clr.14397

Vancouver

Latimer J, Yilmaz B, Feher B, Shiba T, Fretwurst T, Mitlak B, et al. Abaloparatide Enhances Bone Regeneration in Extraction Socket Dental Implant Defects: An Experimental In Vivo Study. Clinical Oral Implants Research. 2025;36(4):471-480. doi:10.1111/clr.14397

BibTeX
@article{Latimer2025,
  author = {Latimer, Jessica and Yilmaz, Birtan and Feher, Balazs and Shiba, Takahiko and Fretwurst, Tobias and Mitlak, Bruce and Lanske, Beate and Kostenuik, Paul and Giannobile, William V},
  title = {Abaloparatide Enhances Bone Regeneration in Extraction Socket Dental Implant Defects: An Experimental In Vivo Study},
  journal = {Clinical Oral Implants Research},
  year = {2025},
  volume = {36},
  number = {4},
  pages = {471--480},
  doi = {10.1111/clr.14397}
}
Kostenlos starten →